A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis
Veronique R de Jager, MD, Prof. Rodney Dawson, MD, Prof. Andreas Diacon
Abstract
This trial will evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of multiple oral doses of OPC-167832 in participants with uncomplicated, smear-positive, drug-susceptible pulmonary tuberculosis (TB).
MeSH terms
- Tuberculosis, Pulmonary